行情

FBIO

FBIO

Fortress Biotech
NASDAQ

实时行情|Nasdaq Last Sale

1.300
+0.020
+1.56%
盘后: 1.330 +0.03 +2.31% 16:00 10/21 EDT
开盘
1.280
昨收
1.280
最高
1.320
最低
1.250
成交量
17.09万
成交额
--
52周最高
2.590
52周最低
0.4900
市值
8,975.51万
市盈率(TTM)
-1.1631
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

FBIO 新闻

  • 中概股收盘:蔚来汽车收涨11.2% 万达体育跌超8%
  • 新浪美股.53分钟前
  • Facebook为2020年美国大选推出打击虚假信息新举措
  • 新浪美股.1小时前
  • 收盘:美股小幅收高 三大股指逼近历史最高纪录
  • 新浪美股.2小时前
  • 孙正义下血本 软银再投40至50亿美元直接控制WeWork
  • 新浪美股.3小时前

更多

所属板块

制药
+0.14%
制药与医学研究
+0.39%

热门股票

名称
价格
涨跌幅

FBIO 简况

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
展开

Webull提供Fortress Biotech Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。